Alnylam Pharmaceuticals
Director Commercial Training – Rare Disease (Finance)
Overview
Alnylam is the industry leader in the translation of RNA interference (RNAi) into a new class of innovative medicines with the potential to address the unmet needs of patients with debilitating diseases. Founded in 2002, Alnylam was built upon a bold vision of turning scientific possibility into reality, and is now advancing a robust pipeline of investigational RNAi therapeutic medicines, including five programs in late-stage development. In 2018, Alnylam received approval for our first product, the first-ever RNAi therapeutic, by the FDA in the U.S. for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults and by the European Medicines Agency in the EU for the treatment of hATTR amyloidosis in adults with stage 1 or stage 2 polyneuropathy. Headquartered in Cambridge, Mass., Alnylam employs over 1,200 people in 18 countries and is rapidly growing globally, with additional offices in Norton, Mass., Maidenhead, U.K., Zug, Switzerland, Amsterdam, Netherlands, and Tokyo, Japan. Alnylam is proud to have been recognized as one of The Boston Globe's Top Places to Work four years in a row (2015-2018) and a Great Place to Work in the U.K. and Switzerland in 2019. Please visit www.alnylam.com for more information.
Be a part of building Alnylam's Enterprise Learning & Development expertise area. The Director Commercial T&D collaborates with multiple functions and regions to develop the learning strategies/plans and systematic execution, that align to and enable business priorities. Lead the implementation of training content & initiatives for new hires and experienced employees across our US Commercial organization, in collaboration with global and functional commercial teams. The individual will create, deliver and facilitate role-specific and product training, as well as interface across various functions within the company to ensure that scientific commercial training activities are structured to enable the achievement of commercial strategies.
Primary responsibilities will include learning analysis, creating, delivering and coordinating new hire's access to training, advanced training, and ongoing skills training. Those deliverables include instructor led training materials, eLearning, mLearning, micro-learning, quick reference materials, end-user guides and compliance certifications. This individual will be expected to manage multiple curricula and resources; work in close collaboration with legal and compliance functions to implement approved learning content.
Summary of Key Responsibilities
Qualifications
Alnylam Pharmaceuticals is an EEO employer committed to an exciting, diverse, and enriching work environment.